FAMILIAL FACTORS IN BARRETT'S ESOPHAGUS
巴雷特食管的家族因素
基本信息
- 批准号:6634749
- 负责人:
- 金额:$ 13.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-08-15 至 2006-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant)
Advances in basic sciences often translate into an increased understanding of
disease processes. Similarly, advances in endoscopic engineering also produce
new technology with novel applications in clinical gastroenterology. I believe
that patient-oriented researchers in gastrointestinal diseases and
gastrointestinal endoscopy must translate advances in basic sciences and
engineering technology to improved methods for patient care. Using my previous
experience in basic research and training in advanced endoscopy, I have
initiated and successfully implemented investigations that address this goal.
My research objectives have been furthered by the opportunity to mentor several
advanced gastroenterology fellows in the performance of specialized endoscopic
procedures and patient-oriented research projects. These trainees are now
productive clinical investigators in the field of gastrointestinal endoscopy.
Protected time provided by this award will permit me to develop a meaningful
research program that focuses on applying new endoscopic techniques and
advances in human genetics to the evaluation of Barrett's esophagus and
esophageal adenocarcinoma. The award will also further my education in two
areas in which it is slightly deficient, viz., biostatistics and human
genetics. Educational courses in these subjects and collaborations with experts
in these fields will strengthen the development of my research program. Lastly,
the award will allow me to teach advanced endoscopy to new trainees and mentor
them in the development of their own research projects within my program.
Esophageal adenocarcinoma is associated with a very poor prognosis. More
effective screening, surveillance, and treatment strategies are required. The
aim of the current proposal is to identify familial factors involved in the
development of Barrett's esophagus and esophageal adenocarcinoma. The ultimate
goal of this research program is to help identify the heritable genetic
mutation(s) that determine susceptibility to Barrett's esophagus in order to
improve screening and surveillance strategies for this disease.
描述(由申请人提供)
基础科学的进步往往转化为对
疾病过程。同样,内窥镜工程的进步也产生了
在临床胃肠病学中具有新应用的新技术。我相信
以病人为导向的研究人员在胃肠道疾病和
胃肠道内窥镜检查必须将基础科学的进步转化为
工程技术,以改善病人护理的方法。使用我以前的
在基础研究和先进的内窥镜培训经验,我有
启动并成功实施了旨在实现这一目标的调查。
我的研究目标得到了进一步的机会,指导几个
高级胃肠病学研究员在专业内窥镜的性能
程序和以病人为导向的研究项目。这些学员现在
胃肠内窥镜检查领域的富有成效的临床研究者。
这个奖项提供的保护时间将允许我发展一个有意义的
研究计划,重点是应用新的内窥镜技术,
人类遗传学在评估Barrett食管方面的进展,
食管腺癌该奖项也将进一步我的教育在两个
有些地方稍有欠缺,即,生物统计学与人类
遗传学这些主题的教育课程和与专家的合作
在这些领域的研究将加强我的研究计划的发展。最后,
该奖项将使我能够向新学员和导师教授先进内窥镜检查术
他们在我的项目中开发自己的研究项目。
食管腺癌预后极差。更
需要有效的筛查、监测和治疗策略。的
目前建议的目的是确定涉及的家庭因素,
Barrett食管和食管腺癌的发展。最终
这项研究计划的目标是帮助确定遗传基因,
决定Barrett食管易感性的突变,
改进对这一疾病的筛查和监测战略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AMITABH CHAK其他文献
AMITABH CHAK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AMITABH CHAK', 18)}}的其他基金
Pathways of Injury and Repair in Barrett's Carcinogenesis
巴雷特癌发生过程中的损伤和修复途径
- 批准号:
10713938 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Deciphering the Molecular Genetics of VSIG10L in Barrett's Neoplasia
破译巴雷特瘤形成中 VSIG10L 的分子遗传学
- 批准号:
10713939 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
巴雷特食管和食管腺癌的遗传决定因素
- 批准号:
9325717 - 财政年份:2011
- 资助金额:
$ 13.24万 - 项目类别:
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
巴雷特食管和食管腺癌的遗传决定因素
- 批准号:
10153699 - 财政年份:2011
- 资助金额:
$ 13.24万 - 项目类别:
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
巴雷特食管和食管腺癌的遗传决定因素
- 批准号:
8546709 - 财政年份:2011
- 资助金额:
$ 13.24万 - 项目类别:
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
巴雷特食管和食管腺癌的遗传决定因素
- 批准号:
8918503 - 财政年份:2011
- 资助金额:
$ 13.24万 - 项目类别:
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
巴雷特食管和食管腺癌的遗传决定因素
- 批准号:
9276253 - 财政年份:2011
- 资助金额:
$ 13.24万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别: